Insider Transactions in Q3 2025 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2025
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,217
-8.94%
|
$13,302
$6.99 P/Share
|